Philipe de Souto Barreto1,2, Laurent Demougeot3, Bruno Vellas1,2, Yves Rolland1,2. 1. Gerontopole of Toulouse, Institute on Aging, Toulouse University Hospital (CHU Toulouse), France. 2. UMR INSERM 1027, University of Toulouse III, France. 3. Center of Genetics, Children's Hospital, Dijon, France.
Abstract
Background: To assess the effects of long-term exercise on the onset of dementia, mild cognitive impairment (MCI), and other clinically meaningful cognitive decline in the elderly adults. Methods: Systematic review with preplanned meta-analysis. Electronic searches were performed between November 2016 and May 2017. Randomized controlled trials (RCTs) examining the effects of long-term exercise (intervention length 12 months or longer) on the onset of dementia, MCI, or clinically meaningful cognitive decline in older adults without dementia at baseline were eligible. Two authors extracted the data independently. Four binary outcomes were defined: dementia onset, MCI onset, other clinically meaningful cognitive decline, and any of these three outcomes combined. Results: Five studies (n = 2,878 participants randomized) were included in this review. Outcomes' incidence for exercisers and controls were, respectively: 3.7% (n = 949) and 6.1% (n = 1,017) for dementia (three studies), 10.2% (n = 686) and 9.1% (n = 682) for MCI (one study), 14.5% (n = 124) and 15.4% (n = 123) for other clinically meaningful cognitive decline (two studies), and 11.4% (n = 1,073) and 12.5% (n = 1,140) for all outcomes combined. Meta-analyses found no significant effects of exercise for reducing the risk of dementia, MCI, other clinically meaningful cognitive decline, or all outcomes combined. Conclusions: Evidence from RCTs is limited and does not support that exercise reduces the risk of developing clinically important cognitive outcomes. Further long-term exercise RCTs are needed before solid conclusions can be drawn.
Background: To assess the effects of long-term exercise on the onset of dementia, mild cognitive impairment (MCI), and other clinically meaningful cognitive decline in the elderly adults. Methods: Systematic review with preplanned meta-analysis. Electronic searches were performed between November 2016 and May 2017. Randomized controlled trials (RCTs) examining the effects of long-term exercise (intervention length 12 months or longer) on the onset of dementia, MCI, or clinically meaningful cognitive decline in older adults without dementia at baseline were eligible. Two authors extracted the data independently. Four binary outcomes were defined: dementia onset, MCI onset, other clinically meaningful cognitive decline, and any of these three outcomes combined. Results: Five studies (n = 2,878 participants randomized) were included in this review. Outcomes' incidence for exercisers and controls were, respectively: 3.7% (n = 949) and 6.1% (n = 1,017) for dementia (three studies), 10.2% (n = 686) and 9.1% (n = 682) for MCI (one study), 14.5% (n = 124) and 15.4% (n = 123) for other clinically meaningful cognitive decline (two studies), and 11.4% (n = 1,073) and 12.5% (n = 1,140) for all outcomes combined. Meta-analyses found no significant effects of exercise for reducing the risk of dementia, MCI, other clinically meaningful cognitive decline, or all outcomes combined. Conclusions: Evidence from RCTs is limited and does not support that exercise reduces the risk of developing clinically important cognitive outcomes. Further long-term exercise RCTs are needed before solid conclusions can be drawn.
Authors: Julene K Johnson; Anita L Stewart; Michael Acree; Anna M Nápoles; Jason D Flatt; Wendy B Max; Steven E Gregorich Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-02-14 Impact factor: 4.077
Authors: Kirk I Erickson; Charles Hillman; Chelsea M Stillman; Rachel M Ballard; Bonny Bloodgood; David E Conroy; Richard Macko; David X Marquez; Steven J Petruzzello; Kenneth E Powell Journal: Med Sci Sports Exerc Date: 2019-06 Impact factor: 5.411
Authors: Ronald M Lazar; Virginia J Howard; Walter N Kernan; Hugo J Aparicio; Deborah A Levine; Anthony J Viera; Lori C Jordan; David L Nyenhuis; Katherine L Possin; Farzaneh A Sorond; Carole L White Journal: Stroke Date: 2021-03-15 Impact factor: 7.914
Authors: Dreu White; Casey S John; Ashley Kucera; Bryce Truver; Rebecca J Lepping; Paul J Kueck; Phil Lee; Laura Martin; Sandra A Billinger; Jeffrey M Burns; Jill K Morris; Eric D Vidoni Journal: Sci Rep Date: 2021-06-17 Impact factor: 4.996
Authors: Davy Vancampfort; Lee Smith; Brendon Stubbs; Nathalie Swinnen; Joseph Firth; Felipe B Schuch; Ai Koyanagi Journal: PLoS One Date: 2018-08-30 Impact factor: 3.240
Authors: Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam Journal: Lancet Date: 2020-07-30 Impact factor: 79.321